A1265 - 2'-FL DFL, LNT, 6'-SL sodium salt and 3'-SL sodium salt for use as nutritive substances in infant formula products

This application seeks to permit the voluntary use of four human-identical milk oligosaccharide (HiMO) ingredients produced by microbial fermentation, alone or in combinations, as nutritive substances in infant formula products (IFP) namely:

Mixture of 2'-fucosyllactose (2'-FL) and difucosyllactose (DFL) (“2' FL/DFL');
Lacto-N-tetraose (LNT);
6'-Sialyllactose (6'-SL) sodium salt; and
3'-Sialyllactose (3'-SL) sodium salt.

The four HiMO ingredients are produced from the same genetically engineered Escherichia coli (E. coli) K-12-derived platform strain as Glycom's 2'-FL and LNnT which is already authorised for use in Australia and New Zealand.